Skip to main content
. 2022 Jun 27;11(13):3705. doi: 10.3390/jcm11133705

Table 3.

Demographic information of all patients with different follow-up periods.

<2 Years
(n = 11)
2–4 Years
(n = 18)
>4 Years
(n = 7)
ap Value
Gender, n (%) 0.182
 Female 7 (63.6) 14 (77.8) 7 (100)
 Male 4 (36.4) 4 (22.2) 0 (0)
Age (year) ± SE (range) 59.5 ± 2.1 (48–77) 57.8 ± 2.8 (34–75) 62.3 ± 1.3 (56–66) 0.454
BH (cm) ± SE (range) 157.1 ± 1.5 (148–165) 159.4 ± 1.6 (150–174) 153.6 ± 1.0 (150–157) 0.810
BW (kg) ± SE (range) 63.0 ± 2.8 (45–75) 64.7 ± 3.1 (46–93) 56.6 ± 4.0 (45–76) 0.936
DM (%) 1 (9.1) 8 (44.4) 1 (14.3) 0.104
Hypertension (%) 2 (18.2) 6 (33.3) 0 (0) 0.216
Lesion site, n (%) 0.903
 Left 4 (36.4) 9 (50.0) 3 (42.9)
 Right 7 (63.6) 9 (50.0) 4 (57.1)
Duration (month) ± SE (range) 10.4 ± 4.3 (1–48) 12.7 ± 2.9 (2–38) 28.6 ± 5.6 (12–48) 0.016
Classification (%) 0.113
Persistent 7 (63.6) 14 (77.8) 2 (28.6)
Recurrence 4 (36.4) 4 (22.2) 5 (71.4)
CSA (mm2) (SE) 14.0 ± 1.1 15.1 ± 1.4 11.6 ± 1.0 0.414
No. of injection (SE) 3.7 ± 0.5 3.1 ± 0.5 2.3 ± 0.6 0.206
Outcome 0.077
Effective 4 (36.4) 14 (77.8) 4 (57.1)
Poor 7 (63.6) 4 (22.2) 3 (42.9)
Other treatment, (%) 2 (18.2) 7 (38.9) 2 (28.6) 0.640
Follow-up period (months) (SE) (range) 14.6 ± 2.1 (6–23) 35.1 ± 2.0 (25–47) 56.7 ± 2.6 (50–67) <0.001

BH = Body height; BW = Body weight; DM = Diabetes mellitus; CSA = Cross-sectional area; SE = standard error. a Kruskal–Wallis test, Fisher’s Exact Test.